ASSESSMENT OF THE HIV INFECTION RISK
HIV Resistance Sensor
The HIV Resistance Sensor provides information on the individual risk of infection with HIV.
The HIV Resistance Sensor provides information on the individual risk of infection with HIV.
The Human Immunodeficiency Virus (HIV) has spread worldwide since the 1980s and is estimated to have cost nearly 40 million lives. Despite medical progress and declining death rates, more than 1.2 million people died in 2014 alone as a result of their HIV infection.
HIV is transmitted through contact with body fluids such as blood, in which the virus can enter the body through small wounds, for example. The most common route of infection is unprotected sexual intercourse.
Although there is no one hundred percent protection against HIV infection, not all people are at the same risk of actually contracting the virus if they come into contact with it.
Depending on their genetic predisposition, there are sometimes considerable differences that can either significantly reduce or increase the risk of infection. An analysis of the relevant genes makes it possible to assess, to which of these groups a person belongs.
For our HIV Resistance Sensor, our laboratory analyses the CCR5 gene relevant to the HIV infection risk. We are also investigating around 40 gene variants concerning the efficacy of 30 drugs.
The test can be used to determine whether a patient is highly or very unlikely to be infected with HIV and what treatment might be required.
Once the test has been successfully completed, we summarize our test results in a precise written evaluation.
In this way, our HIV Resistance Sensor can help to determine the individual risk of infection with HIV and provide valuable information on the correct treatment.
The DNAhealth Control analyzes are not offered by Novogenia.
After a successful analysis, we summarize the individual results in a detailed result report. You will also find information on the analyzed genes and the underlying science in this demo.
We would be happy to send you the demo report. Just send us an email with the name of the analysis.
You might also be interested
in these products: